Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Details Narrative)

v3.21.2
Common Stock (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Jul. 02, 2021
May 07, 2021
Mar. 10, 2020
Feb. 28, 2020
Jan. 31, 2020
Jan. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Aug. 06, 2021
Aug. 05, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                      
Common stock, shares authorized             150,000,000   150,000,000 100,000,000 100,000,000
Common stock, par value             $ 0.001       $ 0.001
Common Stock, Shares, Outstanding             97,468,755       70,438,755
Common Stock, Shares, Issued             97,468,755       70,438,755
Share issued price per share             $ 1.05        
Proceeds from common stock             $ 38,505,000 $ 32,161,000      
At The Market Offering Agreement [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued           1,030,000          
Proceeds from common stock           $ 2,072,000,000,000          
At The Market Offering Agreement [Member] | Maximum [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Proceeds from common stock $ 10,000,000                    
IPO [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Number of shares issued     5,037,038 8,461,540 3,492,063            
Share issued price per share     $ 1.35 $ 1.30 $ 0.63            
Proceeds from common stock     $ 5,000,000.0 $ 10,100,000 $ 1,500,000            
Underwritten Public Offering [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Share issued price per share   $ 1.54                  
Sale of stock offering shares   26,000,000                  
Sale of stock, net proceeds   $ 36,400,000